Skip to main content
. 2019 Sep 26;37(34):3223–3233. doi: 10.1200/JCO.18.02309

FIG 3.

FIG 3.

Multivariable analysis of the effects of prognostic factors on (A) 3-year disease-free survival and (B) locoregional recurrence. CEA, carcinoembryonic antigen; FU, fluorouracil; mFOLFOX6, modified infusional fluorouracil, leucovorin, and oxaliplatin; OR, odds ratio; RT, radiotherapy.